how much protein do you need on tirzepatide Pacing Tirzepatide: Protect Muscle & Support Metabolism 🧬 GLP-1 DOs & DON'Ts

GLP-1 infusion in a patient with Cushings disease induced diabetes has indeed demonstrated similar insulinotropic, glucagonostatic and glucose-lowering actions as in patients with type 2 diabetes (31)

Hori M, Hasegawa Y, Hayashi Y, Nakagami T, Harada-Shiba M

We were able to include nearly 400,000 patients overall, and about 41,000 patients who were treated with GLP-1s, so a very large patient population using all the different kinds of GLP-1 medications

Understanding whether combination therapy aligns with your metabolic profile requires more than protocol familiarityit demands insight into your genetic predispositions in appetite-regulation and GLP-1 signaling pathways